No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Morgan Stanley Assumes Quest Diagnostics at Equal-Weight, Announces Price Target of $142
Morgan Stanley analyst Erin Wright assumes Quest Diagnostics (NYSE:DGX) with a Equal-Weight rating and announces Price Target of $142.
Masimo’s (MASI) Q2 Earnings Surpass Estimates, Margins Down
Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.
Drug Testing At Work Is A Thing Of The Past, Study Finds
According to a study conducted by Quest Diagnostics Inc (NYSE: DGX), drug use among American employees, as measured by the percentage of employees who tested positive in urine drug tests, hit a
Credit Suisse Maintains Neutral on Quest Diagnostics, Lowers Price Target to $143
Credit Suisse analyst A.J. Rice maintains Quest Diagnostics (NYSE:DGX) with a Neutral and lowers the price target from $158 to $143.
Earnings Scheduled For July 21, 2022
Companies Reporting Before The Bell
• SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.
Earnings Preview For Quest Diagnostics
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement.
Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.20.
Quest Diagnostics Unveils Monkeypox Test: What You Need To Know
Quest Diagnostics (NYSE: DGX) has announced the nationwide availability of a lab-developed, automated molecular diagnostic test to identify if a person is infected with monkeypox.
Quest Diagnostics Launches Monkeypox Virus Testing
Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response
Physicians can order the novel Quest Diagnostics lab test beginning today and the CDC